Advertisement

Topics

Takeda's Adcetris gains NICE recommendation for Hodgkin lymphoma

05:40 EDT 19 Jun 2017 | SmartBrief

The National Institute for Health and Care Excellence has recommended use of Takeda's Adcetris, or brentuximab vedotin, as a  -More

Original Article: Takeda's Adcetris gains NICE recommendation for Hodgkin lymphoma

NEXT ARTICLE

More From BioPortfolio on "Takeda's Adcetris gains NICE recommendation for Hodgkin lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...